Cryo-Save Group N.V. Gongslag ter ere van 1 jaar beursnotering
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, heeft vandaag om 9 uur de handelsdag geopend met de gongslag ter ere van 1 jaar notering aan NYSE Euronext Amsterdam.
Het aandeel Cryo-Save heeft een significante groei laten zien van de liquiditeit gedurende dit eerste jaar.
Cryo-Save Group N.V. rings the opening bell to celebrate its first full year on Euronext
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading adult stem cell storage bank, has rung the opening bell at NYSE Euronext Amsterdam today to mark its first full year of being listed on the exchange.
Cryo-Save noticed a significant growth in liquidity of its shares during this year.
Cryo-Save appoints Kempen & Co as liquidity provider
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, today announces that it has decided to appoint Kempen & Co as liquidity provider as of 2 August 2010.
With the appointment of a liquidity provider Cryo-Save aims to enhance the liquidity of its shares on Euronext Amsterdam.
Cryo-Save benoemt Kempen & Co als liquidity provider
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, maakt vandaag bekend Kempen & Co per 2 augustus 2010 te hebben benoemd als liquidity provider.
Met het aanstellen van een liquidity provider stelt Cryo-Save zich ten doel de liquiditeit van het aandeel op Euronext Amsterdam te vergroten.
This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, South Africa or any jurisdiction in which the same would be unlawful. This announcement is not an offer of securities in the United States, Canada, South Africa, Australia, Japan or any other jurisdiction.
This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, South Africa or any jurisdiction in which the same would be unlawful. This announcement is not an offer of securities in the United States, Canada, South Africa, Australia, Japan or any other jurisdiction.
This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, South Africa or any jurisdiction in which the same would be unlawful. This announcement is not an offer of securities in the United States, Canada, South Africa, Australia, Japan or any jurisdiction in which the same would be unlawful.
Cryo-Save Group N.V. (AIM: CRYO, “Cryo-Save”), Europe’s leading stem cell bank, plans to seek an additional listing on Euronext Amsterdam in the fourth quarter of the current financial year to complement the Group’s shares being traded on AIM in London. Cryo-Save was admitted to trading on AIM on 6 November 2007.
Cryo-Save intends to review the need to maintain the AIM listing in early 2010.